Sandbox fungal meningitis: Difference between revisions
Jump to navigation
Jump to search
Line 198: | Line 198: | ||
{| | {| | ||
|- | |- | ||
| valign=top | | | valign=top | | ||
Line 207: | Line 205: | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
|- | |- | ||
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[albendazole]]''''' | | style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[albendazole]]''''' | ||
|- | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:39em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|[[Amebic meningoencephalitis]]}}'' | |||
|- | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:39em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|[[Eosinophilic myeloencephalitis, Meningitis]]}}'' | |||
|- | |||
| valign=top | | |||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:39em" cellpadding="0" cellspacing="0"; | |||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|[[Toxoplasma gondii, Meningitis]]}}'' | |||
|- | |- | ||
|} | |} | ||
|} | |} | ||
==M. tuberculosis Meningitis== | ==M. tuberculosis Meningitis== |
Revision as of 20:29, 22 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]
fungal meningitis
Blastomyces
|
Candidiasis
|
Histoplasma
|
Coccidioides[1]
|
Cryptococcus HIV/AIDS[2]
|
Cryptococcus Immunocompetent[3]
|
Viral Meningitis[4]
|
Parasitic Meningitis
Angiostrongyliasis
|